Navigating Primary MPGN and C3 Glomerulopathy
At a Glance
Primary MPGN is not a single disease but a pattern of kidney injury often driven by an overactive immune system. Determining whether you have Immune Complex-mediated MPGN or C3 Glomerulopathy is the critical first step in finding the right targeted treatment for your kidneys.
Being diagnosed with Primary Membranoproliferative Glomerulonephritis (MPGN) or C3 Glomerulopathy (C3G) is a life-changing event. You likely feel overwhelmed, confused by the medical jargon, and worried about your future. This guide is designed to empower you with evidence-based information so you can understand your condition, ask the right questions, and partner effectively with your medical team.
What is Primary MPGN?
MPGN is a rare and complex condition that affects the glomeruli, the tiny filters in your kidneys. Importantly, MPGN is not a single disease—it is a pattern of injury seen under a microscope. It tells your doctor how your kidney is being damaged, but not always why [1][2].
Historically, doctors used a numbering system (Type I, II, III). Today, the disease is classified based on what part of your immune system is causing the damage:
- Immune Complex-mediated MPGN (IC-MPGN): Driven by antibodies and complement proteins [3].
- C3 Glomerulopathy (C3G): Driven by an overactive “alternative complement pathway” [4].
When your doctor says the disease is primary, it means they have ruled out outside causes like infections or other autoimmune diseases. The problem originates within your immune system itself [5].
Navigating This Guide
This resource is broken down into specific topics to help you manage your diagnosis step-by-step:
Validation & Orientation: Understanding a Primary MPGN Diagnosis
Learn what a primary MPGN diagnosis means. Understand why it's a pattern of kidney injury, the difference between IC-MPGN and C3G, and new treatment options.
Symptoms and Warning Signs of MPGN
Learn the key symptoms and warning signs of MPGN and C3G. Understand what foamy or tea-colored urine, edema, and high blood pressure mean for kidney health.
Biology and Secondary Causes: Getting the Right Diagnosis
Learn the biology of membranoproliferative glomerulonephritis (MPGN). Understand the complement system and why ruling out secondary causes like MGRS is vital.
Pathology & Understanding Your Kidney Biopsy Report
Learn how to read your MPGN or C3G kidney biopsy report. Understand light microscopy, immunofluorescence, electron microscopy, and what your results mean.
Treatment Strategy: Standard of Care and New Targeted Therapies
Explore MPGN and C3G treatment options. Learn how supportive care, immunosuppression, and new targeted complement inhibitors work to protect your kidneys.
Building Your Care Team and Preparing for Visits
Learn how to build an expert care team for primary MPGN and C3G. Discover which specialists you need, how to prepare for visits, and what questions to ask.
Prognosis & Survivorship: Monitoring Your Long-Term Health
Learn about the long-term prognosis for MPGN and C3G. Understand kidney function monitoring, eGFR, UPCR labs, and what to expect with kidney transplant.
You do not have to read this all at once. Take it one step at a time. The landscape of MPGN and C3G treatment is changing rapidly, and a diagnosis today comes with more targeted options and hope than ever before [6].
Common questions in this guide
What is the difference between MPGN and C3 Glomerulopathy?
What does it mean if my MPGN diagnosis is primary?
What kind of doctor should treat primary MPGN?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can you explain where I am in the diagnostic process? Have we confirmed whether this is primary or secondary?
- 2.Who else needs to be on my care team? Should I be seeing a specialized glomerular disease nephrologist?
- 3.What is my most recent eGFR and UPCR, and what are our target goals for these numbers?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (6)
- 1
Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations.
Lafayette RA, Charu V, Glassock RJ
Advances in therapy 2025; (42(5)):2003-2014 doi:10.1007/s12325-025-03167-x.
PMID: 40146368 - 2
A case report of recurrent membranoproliferative glomerulonephritis after kidney transplantation due to ventriculoatrial shunt infection.
Völker LA, Burkert K, Scholten N, et al.
BMC nephrology 2019; (20(1)):296 doi:10.1186/s12882-019-1472-1.
PMID: 31382904 - 3
De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?
Abbas F, El Kossi M, Jin JK, et al.
World journal of transplantation 2017; (7(6)):285-300 doi:10.5500/wjt.v7.i6.285.
PMID: 29312858 - 4
Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy Phenotype.
Roquigny J, Meuleman MS, El Sissy C, et al.
Journal of the American Society of Nephrology : JASN 2025; (36(2)):264-273 doi:10.1681/ASN.0000000000000499.
PMID: 39325562 - 5
C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
Alonso-Titos J, Perea-Ortega L, Sola E, et al.
BMC nephrology 2018; (19(1)):129 doi:10.1186/s12882-018-0927-0.
PMID: 29884135 - 6
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.
Fakhouri F, Bomback AS, Ariceta G, et al.
The New England journal of medicine 2025; (393(22)):2210-2220 doi:10.1056/NEJMoa2501510.
PMID: 41337715
This page provides an educational overview of Primary MPGN and C3 Glomerulopathy for informational purposes only. It is not a substitute for professional medical advice from a qualified nephrologist.
Get notified when new evidence is published on Primary membranoproliferative glomerulonephritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.